How to take Bimekizumab

Before starting treatment with bimekizumab, doctors evaluate patients for tuberculosis infection; test liver enzymes, alkaline phosphatase, and bilirubin. Patients should complete all age-appropriate vaccinations as recommended by current immunization guidelines. Before injection, remove the carton containing Bhimizumab from the refrigerator and allow it to reach room temperature (30 to 45 minutes) without removing the prefilled syringe or autoinjector from the carton to avoid light exposure.

The recommended dose of bimeclizumab is 320 mg (2 subcutaneous injections of 160 mg each) at weeks 0, 4, 8, 12, and 16, and every 8 weeks thereafter. For patients weighing ≥120 kg, consider bimeclizumab 320 mg every 4 weeks after week 16. If you miss a dose, use it as soon as possible. Thereafter, resume dosing at regularly scheduled times.

Bimizumab is intended for use under the guidance and supervision of a health care professional. After being trained in subcutaneous injection techniques, patients can inject themselves. Each prefilled syringe or autoinjector of bimekizumab contains 160 mg of bimekizumab-bkzx. For each dose, administer two separate 160 mg single-dose prefilled syringes or auto-injectors subcutaneously at different anatomical locations (e.g., thigh, abdomen, or dorsum of upper arm). Discard syringe or autoinjector after use.

The generic drug Bimeizumab has not yet been launched in the country, so it cannot be included in medical insurance. The European version of bimezumab original drug sold overseas, specifications160mg*2 per box may cost more than 40,000 yuan (the price may fluctuate due to the exchange rate). The price is still relatively high. There is currently no generic version of bimezumab produced and launched. For the specific price and drug information of this drug, please consult a medical consultant.